Article
Biochemistry & Molecular Biology
Michela Marcatti, Anna Fracassi, Mauro Montalbano, Chandramouli Natarajan, Balaji Krishnan, Rakez Kayed, Giulio Taglialatela
Summary: This study demonstrates that Tau oligomers become the main synaptotoxic species in late-stage Alzheimer's disease (AD), supporting the hypothesis that targeting Tau oligomers may be the most effective therapeutic approach for clinically manifest AD.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2022)
Article
Multidisciplinary Sciences
Kevin A. Murray, Carolyn J. Hu, Sarah L. Griner, Hope Pan, Jeannette T. Bowler, Romany Abskharon, Gregory M. Rosenberg, Xinyi Cheng, Paul M. Seidler, David S. Eisenberg
Summary: Neurodegenerative diseases are characterized by the accumulation of aggregated proteins, and inhibiting the formation of these aggregates is a potential therapeutic strategy. Using de novo protein design, researchers have developed a library of mini-protein inhibitors that specifically target the amyloid structures of tau, Aβ, and α Syn. These inhibitors show promising results in preventing aggregation and rescuing motor deficits in animal models of PD and AD.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Cell Biology
Anagh Sinha Ravi, Menglong Zeng, Xudong Chen, Gerardo Sandoval, Javier Diaz-Alonso, Mingjie Zhang, Roger A. Nicoll
Summary: Recent research suggests that the TARP/PSD-95 complex is an essential interaction underlying AMPAR trafficking and LTP. The interaction between PSD-95 and AMPAR auxiliary subunits TARPs can capture AMPARs and enhance synaptic transmission and LTP.
Review
Biochemistry & Molecular Biology
Huiqin Zhang, Wei Wei, Ming Zhao, Lina Ma, Xuefan Jiang, Hui Pei, Yu Cao, Hao Li
Summary: Extracellular neuritic plaques and intracellular neurofibrillary tangles, composed of amyloid-beta and phosphorylated tau protein respectively, are hallmark proteins of Alzheimer's disease. The interactions between these proteins have been extensively studied, with A beta accelerating tau phosphorylation, tau mediating A beta toxicity, and potential synergistic effects on microglial cells and astrocytes. Understanding these interactions may lead to new interventions against Alzheimer's disease.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2021)
Review
Cell Biology
Martina Gabrielli, Francesca Tozzi, Claudia Verderio, Nicola Origlia
Summary: Alzheimer's disease (AD) is characterized by synaptic failure, with extracellular vesicles (EVs) released by brain cells playing a crucial role in the early stages. This review examines the contribution of EVs from different brain cells to neuronal alterations and proposes a model for EV-mediated propagation of synaptic dysfunction in early AD. Understanding the interaction between EVs and neurons may lead to new therapeutic approaches for AD.
Article
Medicine, Research & Experimental
Maria Eleni Karakatsani, Robin Ji, Maria F. Murillo, Tara Kugelman, Nancy Kwon, Yeh-Hsing Lao, Keyu Liu, Antonios N. Pouliopoulos, Lawrence S. Honig, Karen E. Duff, Elisa E. Konofagou
Summary: This study investigates the effects of repeated bilateral sonication in the presence of both amyloid plaques and hyperphosphorylated tau protein in mouse models of Alzheimer's disease. The results show that bilateral focused ultrasound (FUS) treatment significantly improves spatial memory and reduces both pathologies. Preliminary clinical evidence also suggests that FUS treatment can reduce amyloid plaques in humans.
Article
Chemistry, Multidisciplinary
Seung Hwan Son, Na-Rae Lee, Min Sung Gee, Chae Won Song, Soo Jin Lee, Sang-Kyung Lee, Yoonji Lee, Hee Jin Kim, Jong Kil Lee, Kyung-Soo Inn, Nam-Jung Kim
Summary: The researchers reported a protein degrader, PRZ-18002, that selectively binds to an active form of p38 MAPK and induces degradation of phosphorylated p38 MAPK. Treatment with PRZ-18002 reduces p-p38 levels, alleviates microglia activation and amyloid beta (Aβ) deposition, and improves spatial learning and memory, suggesting its potential therapeutic effect for Alzheimer's disease (AD).
ACS CENTRAL SCIENCE
(2023)
Article
Biochemistry & Molecular Biology
Lenka Hromadkova, Chae Kim, Tracy Haldiman, Lihua Peng, Xiongwei Zhu, Mark Cohen, Rohan de Silva, Jiri G. Safar
Summary: This study aimed to investigate the impact of different mutated tau conformers on the phenotypic variations of Alzheimer's disease (AD) and synaptic loss. By inoculating structurally-characterized Sarkosyl-insoluble tau isolates from AD cases into wild-type mouse neurons, it was found that different mutated tau conformers induced aggregation at different rates and exhibited distinct conformational characteristics in mature neurons. The correlation between the formation of mutated tau aggregates and synaptic loss further confirmed the presence of diverse mutated tau aggregates with different synaptic interactors.
CELL AND BIOSCIENCE
(2023)
Review
Biochemistry & Molecular Biology
Chang Youn Lee, In Soo Ryu, Jin-Hyeob Ryu, Hyun-Jeong Cho
Summary: Alzheimer's disease is a progressive neurodegenerative disorder, with miRNAs playing a crucial role in its pathological processes. Limitations of current pharmaceutical therapies have led to research on miRNA-based next-generation therapies.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Chemistry, Medicinal
Kirsty Hamilton, Jenni Harvey
Summary: Leptin plays a significant role in regulating synaptic function in the hippocampus, enhancing cognitive function and memory tasks. It also targets temporoammonic-CA1 synapses, which are important for spatial and episodic memory processes. Leptin may have neuroprotective effects in Alzheimer's disease and boosting its actions in the hippocampus could be beneficial for AD patients.
Article
Neurosciences
Senthilkumar Krishnamoorthi, Ashok Iyaswamy, Sravan Gopalkrishnashetty Sreenivasmurthy, Abhimanyu Thakur, Karthick Vasudevan, Gaurav Kumar, Xin-Jie Guan, Kejia Lu, Isha Gaurav, Cheng-Fu Su, Zhou Zhu, Jia Liu, Yuxuan Kan, Selvaraj Jayaraman, Zhiqiang Deng, Ka Kit Chua, King-Ho Cheung, Zhijun Yang, Ju-Xian Song, Min Li
Summary: This study demonstrates that Caudatin can activate the PPARα-dependent ALP pathway, promoting the clearance of Aβ and phosphorylated-Tau in AD, thereby reducing the progression of the disease and improving cognitive dysfunction.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
(2023)
Article
Neurosciences
Margrethe A. Olesen, Rodrigo A. Quintanilla
Summary: Tau protein is involved in various important functions in the central nervous system, such as maintaining cellular structure, facilitating axonal transport, and promoting synaptic communication. Studies have focused on understanding the role of tau modifications in Alzheimer's disease, particularly the cleavage of tau by caspases and its impact on neuronal function. Cleaved tau has been shown to contribute to oxidative damage, cognitive decline, and neurodegenerative manifestations in Alzheimer's disease. This review explores the significance of caspase-cleaved tau in the pathogenesis of Alzheimer's disease and its detrimental effects on neuronal function.
MOLECULAR NEUROBIOLOGY
(2023)
Article
Neuroimaging
Letizia Vogler, Anna Ballweg, Bernd Bohr, Nils Briel, Karin Wind, Melissa Antons, Lea H. Kunze, Johannes Gnoerich, Simon Lindner, Franz-Josef Gildehaus, Karlheinz Baumann, Peter Bartenstein, Guido Boening, Sibylle I. Ziegler, Johannes Levin, Andreas Zwergal, Guenter U. Hoeglinger, Jochen Herms, Matthias Brendel
Summary: This study aimed to investigate the feasibility of using [F-18]UCB-H PET with synaptic vesicle glycoprotein 2A (SV2A) as an alternative preclinical biomarker for neurodegenerative processes. The results showed that [F-18]UCB-H reliably depicts progressive synaptic loss in PS2APP and P301S transgenic mice, potentially qualifying as a more reliable alternative to [F-18]FDG as a biomarker for assessment of neurodegeneration in preclinical research.
NEUROIMAGE-CLINICAL
(2023)
Article
Neurosciences
Charlotte S. Bold, Danny Baltissen, Susann Ludewig, Michaela K. Back, Jennifer Just, Lara Kilian, Susanne Erdinger, Marija Banicevic, Lena Rehra, Fadi Almouhanna, Martina Nigri, David P. Wolfer, Roman Spilger, Karl Rohr, Oliver Kann, Christian J. Buchholz, Jakob von Engelhardt, Martin Korte, Ulrike C. Muller
Summary: The study reveals the therapeutic potential of APPs alpha in mitigating Tau-induced synaptic deficits. Additionally, loss of interneurons leads to disrupted neuronal circuits, compromising synaptic plasticity and behavior.
JOURNAL OF NEUROSCIENCE
(2022)
Review
Pharmacology & Pharmacy
Khaled S. Abd-Elrahman, Stephen S. G. Ferguson
Summary: mGluR5 is widely expressed in the brain and plays a key role in memory and learning, synaptic transmission, and plasticity. Its dysfunction, specifically in response to Aβ42 oligomers, is believed to contribute to the pathophysiology of AD. As a potential therapeutic target for AD, recent studies have demonstrated the efficacy of mGluR5 allosteric modulators in improving memory deficits and mitigating disease pathology. However, the pharmacological differences and downstream signaling activation of mGluR5 in different genders suggest the need for reevaluation of its therapeutic potential in female AD patients.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Swagata Ghatak, Nima Dolatabadi, Richard Gao, Yin Wu, Henry Scott, Dorit Trudler, Abdullah Sultan, Rajesh Ambasudhan, Tomohiro Nakamura, Eliezer Masliah, Maria Talantova, Bradley Voytek, Stuart A. Lipton
Summary: Early stages of human Alzheimer's disease (AD) show hyperexcitability in the brain, leading to extensive synapse loss and cognitive dysfunction, with no current disease-modifying therapy available. Utilizing human iPSC models may be a valuable tool for screening drugs to treat hyperexcitability and synaptic damage in AD, potentially increasing the chances of success in treatment.
MOLECULAR PSYCHIATRY
(2021)
Review
Pharmacology & Pharmacy
Swagata Ghatak, Maria Talantova, Scott R. McKercher, Stuart A. Lipton
Summary: The balance between excitation and inhibition in a neuronal network, known as excitatory/inhibitory (E/I) balance, is crucial for normal brain function. In pathological conditions, this balance can be disrupted, leading to E/I imbalance and network dysfunction. Developing therapies to rebalance neural networks is important for improving neurological function in diseases associated with E/I imbalance.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021
(2021)
Article
Neurosciences
Dorit Trudler, Sara Sanz-Blasco, Yvonne S. Eisele, Swagata Ghatak, Karthik Bodhinathan, Mohd Waseem Akhtar, William P. Lynch, Juan C. Pina-Crespo, Maria Talantova, Jeffery W. Kelly, Stuart A. Lipton
Summary: In Parkinson's disease, synaptic and neuronal loss are prominent features. The study reveals that alpha Syn oligomers induce excessive glutamate release from astrocytes, activating NMDARs on neurons and leading to synaptic damage. However, the drug NitroSynapsin shows promise in protecting synapses from alpha Syn-induced damage.
JOURNAL OF NEUROSCIENCE
(2021)
Article
Multidisciplinary Sciences
Tomohiro Nakamura, Chang-ki Oh, Lujian Liao, Xu Zhang, Kevin M. Lopez, Daniel Gibbs, Amanda K. Deal, Henry R. Scott, Brian Spencer, Eliezer Masliah, Robert A. Rissman, John R. Yates, Stuart A. Lipton
Summary: This study describes mechanistically distinct enzymes that can mediate a series of redox reactions and lead to synapse loss in patients with Alzheimer's disease. These enzymes can form a separate network for aberrant transnitrosylation, which may not be effectively countered by natural selection in the post-reproductive period.
Article
Multidisciplinary Sciences
Elaine Pirie, Chang-Ki Oh, Xu Zhang, Xuemei Han, Piotr Cieplak, Henry R. Scott, Amanda K. Deal, Swagata Ghatak, Fernando J. Martinez, Gene W. Yeo, John R. Yates, Tomohiro Nakamura, Stuart A. Lipton
Summary: This study reveals that environmentally induced nitrosative stress can trigger protein aggregation and cell-to-cell spread, leading to abnormal aggregation of TDP-43 in ALS/FTD. These processes also interfere with neuronal function, contributing to the progression of the diseases.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Biochemistry & Molecular Biology
Tomohiro Nakamura, Chang-ki Oh, Xu Zhang, Steven R. Tannenbaum, Stuart A. Lipton
Summary: Physiological concentrations of nitric oxide and related reactive nitrogen species play important roles in mediating signaling pathways in the nervous system. S-nitrosylation, particularly through transnitrosylation, is a critical chemical mechanism for transduction of redox-mediated events. Future studies should focus on understanding how transnitrosylation regulates various neuronal attributes in aging, inflammation, and neurodegenerative diseases.
ANTIOXIDANTS & REDOX SIGNALING
(2021)
Article
Multidisciplinary Sciences
Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S. Goodwin, Yona Levites, Todd E. Golde, Jeffery W. Kelly, Michael R. Sierks, Nicholas J. Schork, Michael Karin, Rajesh Ambasudhan, Stuart A. Lipton
Summary: Parkinson's disease is associated with the accumulation of alpha-synuclein and activation of microglia, potentially leading to neuronal death. This study shows that alpha-synuclein can activate NLRP3 inflammasome in human microglia and that alpha-synuclein-antibody complexes can exacerbate inflammation in a human context.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Review
Biochemistry & Molecular Biology
Tomohiro Nakamura, Chang-ki Oh, Xu Zhang, Stuart A. Lipton
Summary: Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases are characterized by progressive degeneration of synapses and neurons, often attributed to accumulated misfolded/aggregated proteins. Excessive reactive oxygen and nitrogen species in the brain may contribute to protein misfolding, potentially exacerbated by genetic mutations and environmental factors. Understanding the role of reactive nitrogen species in post-translational modifications of proteins could lead to therapeutic interventions for neurodegenerative diseases.
FREE RADICAL BIOLOGY AND MEDICINE
(2021)
Article
Immunology
Hongxu Xian, Yuan Liu, Alexandra Rundberg Nilsson, Raphaella Gatchalian, Timothy R. Crother, Warren G. Tourtellotte, Yi Zhang, German R. Aleman-Muench, Gavin Lewis, Weixuan Chen, Sarah Kang, Melissa Luevanos, Dorit Trudler, Stuart A. Lipton, Pejman Soroosh, John Teijaro, Juan Carlos de la Torre, Moshe Arditi, Michael Karin, Elsa Sanchez-Lopez
Summary: The study found that metformin can attenuate COVID-19-induced ARDS by inhibiting NLRP3 inflammasome activation, IL-1 beta and IL-6 secretion, and by blocking ATP and mtDNA synthesis.
Review
Biochemistry & Molecular Biology
Dorit Trudler, Swagata Ghatak, Stuart A. Lipton
Summary: Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease, represent a significant social and economic burden due to increasing prevalence and lack of effective therapies. Lack of reliable models has hindered the development of treatments, but human-induced pluripotent stem cell technology offers a promising alternative to complement animal models for disease modeling and drug discovery.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Neurosciences
Chang-Ki Oh, Nima Dolatabadi, Piotr Cieplak, Maria T. Diaz-Meco, Jorge Moscat, John P. Nolan, Tomohiro Nakamura, Stuart A. Lipton
Summary: This article investigates the mechanism by which dysregulation of autophagic pathways leads to the accumulation of abnormal proteins and damaged organdies in neurodegenerative disorders. The authors found that pathologic protein S-nitrosylation of p62 is a critical factor for autophagic inhibition and cell-to-cell spread.
JOURNAL OF NEUROSCIENCE
(2022)
Review
Biochemistry & Molecular Biology
Takumi Satoh, Dorit Trudler, Chang-Ki Oh, Stuart A. Lipton
Summary: This article reviews the potential applications of carnosic acid (CA) and carnosol (CS) in rosemary for conditions such as Alzheimer's disease, Parkinson's disease, and COVID-19. It highlights the antioxidant, anti-inflammatory, and neuroprotective effects of CA, as well as its potential to inhibit the NLRP3 inflammasome. The article suggests that CA-related compounds could serve as therapeutics for acute and chronic neurological effects caused by SARS-CoV-2 infection and other neurodegenerative diseases.
Article
Biochemistry & Molecular Biology
Ki-Ryeong Kim, Eun-Jung Cho, Jae-Won Eom, Sang-Seok Oh, Tomohiro Nakamura, Chang-ki Oh, Stuart A. Lipton, Yang-Hee Kim
Summary: This study reveals that S-nitrosylation of lysosomal protease cathepsin B (CTSB) inhibits its activity, blocks autophagic flux, and contributes to the pathogenesis of Alzheimer's disease (AD).
CELL DEATH AND DIFFERENTIATION
(2022)
Review
Neurosciences
Morgan G. Stykel, Scott D. Ryan
Summary: This review discusses the role of reactive nitrogen species (RNS), specifically nitric oxide (NO), in the pathogenesis of Parkinson's Disease (PD) and its accumulation, as well as the effects of RNS on the loss of dopaminergic neurons and PD-related phenotypes. Studies have shown that over 1/3 of the proteins deposited in Lewy Bodies are post-translationally modified (S-nitrosylated) by RNS, and therapeutics targeting S-nitrosylation of proteins have shown success in PD-related clinical trials.
NPJ PARKINSONS DISEASE
(2022)
Correction
Neurosciences
Morgan G. Stykel, Scott D. Ryan
NPJ PARKINSONS DISEASE
(2022)